Allovir (ALVR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Mar8

Allovir released FY2024 Q4 earnings on March 7 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -3.636 USD (forecast -1.15 USD)

04:00

Allovir released FY2024 annual earnings on March 7 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -11.7339 USD (forecast -15.6399 USD)

04:00

Mar3

Halper Sadeh LLC's Investigation into AlloVir, Inc.'s Merger

18:57

Nov13

Allovir released FY2024 9 Months Earnings on November 12 (EST) with actual revenue of 0 USD and EPS of -8.1123 USD

04:00

Allovir released FY2024 Q3 earnings on November 12 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -0.8223 USD (forecast -1.15 USD)

04:00

Nov12

AlloVir Acquires Kalaris Therapeutics to Form New Entity

00:46

Schedules & Filings

Schedules

Filings

Mar19

Ticker Change(EST)

From 03.19 changed to KLRS

Mar7

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -18.27 M, EPS -3.636

Jan16

Reverse Stock Split(EST)

1-for-23 Reverse Stock Split

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More